12 results
AACE/ACE 2018 Glycemic Control Algorithm

#AACE #2018 #Glycemic #Diabetes #DM2 #Control #Medication #Algorithm #Endocrinology #PrimaryCare #Management
AACE/ACE 2018 Glycemic ... Control Algorithm ... #AACE #2018 # ... Glycemic #Diabetes #DM2 ... #Control #Medication
Profiles of Antidiabetic Medications - AACE 2018 

#Antidiabetic #Medications #Profiles #SideEffects #Table #DecisionAid #Orals #DM2 #Diabetes
of Antidiabetic Medications ... - AACE 2018 ... #Antidiabetic #Medications ... #SideEffects #Table ... DecisionAid #Orals #DM2
Diabetes Medication Choice
-Diabetes Medication Choice decision aid cards provide information on medications commonly used to treat
Diabetes Medication ... Choice -Diabetes Medication ... information on medications ... patient. ** 2018 ... Diabetes #Type2 #DM2
AACE/ACE 2016 Postmenopausal Osteoporosis Treatment Algorithm

Evaluate for causes of secondary osteoporosis

Correct calcium/vitamin D deficiency and address
AACE/ACE 2016 Postmenopausal ... Osteoporosis Treatment Algorithm ... benefits and risks of medications ... Osteoporosis #AACE #2016 ... Postmenopausal #Treatment #Algorithm
Table of Weight-Loss Medications approved by the FDA for the long-term treatment of Obesity

Mechanism of Action,
Table of Weight-Loss ... Medications approved ... mg #Obesity #Medications ... WeightLoss #AACE #2016 ... #Pharmacology #Table
What interventions do have proven mortality benefit?
The above factors predict that it's nearly impossible to prove
, Ridgeon 2016, ... and Landoni 2015 ... below is a list of medications ... #CriticalCare #Medications ... MortalityBenefit #Table
â–º
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Inhibitor GOLD 2019 ... Dosing: 250 mcg tablet ... daily The 2019 ... exacerbations. 2019 ... the use of this medication
ISCHEMIA Trial - Management Algorithm for patients with Stable Angina

Stress Test -> ? +moderate or severe
Trial - Management Algorithm ... patients with Stable ... ISCHEMIA trial 2019 ... #ISCHEMIA #Stable ... Diagnosis #Management #Algorithm
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
- Allergies to medications ... event, follow ACC algorithm ... PCI/DES ( Levine 2016 ... since ACS ( Levine 2016 ... stroke ( Doherty 2017
SGLT2 Inhibitors 
SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
anti-diabetic medications ... being approved in 2013 ... #Pharmacology #Medications ... #DM2 #Diabetes